Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Elm Street Ventures

Founders Rob Bettigole

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 24
Average round size
info
The average size of a deal this fund participated in
$9M
Portfolio companies 18
Rounds per year 1.41
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.25
Exits 6
Key employees 3
Stages of investment
Early Stage Venture
Late Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Biopharma
  • Pharmaceutical
  • Health Care
  • Therapeutics
Summary

The main department of described VC is located in the New Haven. The venture was found in North America in United States.

The current fund was established by Rob Bettigole. The overall number of key employees were 3.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Elm Street Ventures, startups are often financed by Connecticut Innovations, OUP (Osage University Partners), MPM Capital. The meaningful sponsors for the fund in investment in the same round are Connecticut Innovations, OUP (Osage University Partners), Xeraya Capital. In the next rounds fund is usually obtained by RA Capital Management, OrbiMed, New Leaf Venture Partners.

Deals in the range of 5 - 10 millions dollars are the general things for fund. Comparing to the other companies, this Elm Street Ventures performs on 4 percentage points more the average number of lead investments. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2009. Considering the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations. The higher amount of exits for fund were in 2019.

Among the most popular portfolio startups of the fund, we may highlight Iconic Therapeutics, Retail Optimization, SeeClickFix. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 3 or 5+ of the founder, the probability for it to get the investment is little. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most successful fund investment fields, there are Pharmaceutical, Consumer.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Elm Street Ventures:
Typical Co-investors
Elm Street Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Elm Street Ventures:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
China Investment Corporation Beijing, Beijing, China
City Developments Central, Central Region, Singapore
Elite Joint China, Guangdong, Tianjin
Fuqua Investments -
Mashreq Bank Dubai, United Arab Emirates
Reliance Entertainment -
TaskRabbit California, San Francisco, United States
VKRM Ventures California, Los Altos, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

CellFE

Biotechnology
Health Care
$22M27 Sep 2023 California, United States

Cybrexa Therapeutics

Biotechnology
Pharmaceutical
Therapeutics
$25M10 Mar 2021 New Haven, Connecticut, United States

Artizan Biosciences

Biopharma
Biotechnology
Life Science
$18M01 Mar 2021 New York, New York, United States

Halda Therapeutics

$25M13 Nov 2020 Branford, Connecticut, United States

P2 Science

Biotechnology
Chemical
Renewable Energy
$12M29 Jan 2020 Connecticut, United States

CellFE

Biotechnology
Health Care
$4M16 Jan 2020 California, United States

EvolveImmune Therapeutics

Biotechnology
Health Care
$17M08 Jan 2020 Connecticut, United States

Artizan Biosciences

Biopharma
Biotechnology
Life Science
$12M11 Jun 2019 New York, New York, United States

Saphlux

Electronics
Manufacturing
Semiconductor
$5M22 Mar 2017 Connecticut, United States
News
Cybrexa Therapeutics Completes $25M Series B Financing

– Cybrexa Therapeutics from New Haven develops a new class of therapeutics through its alphalex™ Peptide Drug Conjugate (PDC) tumor targeting platform.
– The company completed its $25m Series B financing.
– Backers included HighCape Capital and new investor Elm Street Ventures.
– The new investment will be aimed at planned advancement of its lead candidate CBX-12 (alphalex™-exatecan) into the clinic.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Elm Street Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 24
Average round size 9M
Rounds per year 1.41
Peak activity year 2020
Lead investments 0
Follow on index 0.25
Exits 6
Group Appearance index 0.92

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

CellFE

Biotechnology
Health Care
$22M27 Sep 2023 California, United States

Cybrexa Therapeutics

Biotechnology
Pharmaceutical
Therapeutics
$25M10 Mar 2021 New Haven, Connecticut, United States

Artizan Biosciences

Biopharma
Biotechnology
Life Science
$18M01 Mar 2021 New York, New York, United States

Halda Therapeutics

$25M13 Nov 2020 Branford, Connecticut, United States

P2 Science

Biotechnology
Chemical
Renewable Energy
$12M29 Jan 2020 Connecticut, United States

CellFE

Biotechnology
Health Care
$4M16 Jan 2020 California, United States

EvolveImmune Therapeutics

Biotechnology
Health Care
$17M08 Jan 2020 Connecticut, United States

Artizan Biosciences

Biopharma
Biotechnology
Life Science
$12M11 Jun 2019 New York, New York, United States

Saphlux

Electronics
Manufacturing
Semiconductor
$5M22 Mar 2017 Connecticut, United States
Crunchbase icon

Content report

The following text will be sent to our editors: